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Abstract
Background Fatigue is one of the most commonly reported subjective symptoms following traumatic brain injury (TBI). 
The aims were to assess frequency of fatigue over the first 6 months after TBI, and examine whether fatigue changes could 
be predicted by demographic characteristics, injury severity and comorbidities.
Methods Patients with acute TBI admitted to 65 trauma centers were enrolled in the study Collaborative European Neuro-
Trauma Effectiveness Research in TBI (CENTER-TBI). Subjective fatigue was measured by single item on the Rivermead 
Post-Concussion Symptoms Questionnaire (RPQ), administered at baseline, three and 6 months postinjury. Patients were 
categorized by clinical care pathway: admitted to an emergency room (ER), a ward (ADM) or an intensive care unit (ICU). 
Injury severity, preinjury somatic- and psychiatric conditions, depressive and sleep problems were registered at baseline. 
For prediction of fatigue changes, descriptive statistics and mixed effect logistic regression analysis are reported.
Results Fatigue was experienced by 47% of patients at baseline, 48% at 3 months and 46% at 6 months. Patients admitted to 
ICU had a higher probability of experiencing fatigue than those in ER and ADM strata. Females and individuals with lower 
age, higher education, more severe intracranial injury, preinjury somatic and psychiatric conditions, sleep disturbance and 
feeling depressed postinjury had a higher probability of fatigue.
Conclusion A high and stable frequency of fatigue was found during the first 6 months after TBI. Specific socio-demographic 
factors, comorbidities and injury severity characteristics were predictors of fatigue in this study.
Keywords Head injury · Post-traumatic fatigue · Longitudinal studies · Neurological disorders
Introduction
Fatigue is defined as "the awareness of a decreased capacity 
for mental and/or physical activity, because of an imbal-
ance in the availability, utilization or restoration of resources 
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needed to perform activities" [1]. It is one of the most com-
monly reported subjective symptoms following traumatic 
brain injury (TBI). Precise estimates of post-TBI fatigue 
vary greatly (21–73%) [24], but it consistently exceeds the 
prevalence of fatigue in the general population (10–20%) 
[21]. The existing evidence shows that self-reported fatigue 
decreases over time after TBI, but some patients continue 
to report persisting fatigue or may even report an increase 
in fatigue over time [27]. A previous study assessing fatigue 
pathways over the first year after TBI showed an increase of 
fatigue after severe TBI (sTBI), stable fatigue after moderate 
TBI and a reduction of fatigue levels over time after mild 
TBI (mTBI) [4]. Other studies have suggested that long-
standing fatigue is not limited to patients with sTBI, and 
may be exacerbated or caused by emotional and cognitive 
symptoms, sleep disturbances, and pain across all injury 
severities [29, 30].
Premorbid variables such as emotional/mental health 
problems, personality traits, pre-existing fatigue, and other 
medical comorbidities may contribute additionally to vul-
nerability for the development of fatigue following TBI [6, 
12]. The association between fatigue and personal factors 
such as age, gender, and education have been assessed to a 
lesser extent [6, 16, 27]. Gender differences in prevalence 
and severity of fatigue have been reported after stroke [20]. 
However, studies after TBI found inconsistent effects of age 
and gender [7, 12, 16, 27], whereas higher education was 
associated with higher levels of fatigue [41].
The majority of previous studies have been conducted 
with patients after mTBI, and at greatly varying time-points 
postinjury [24]. Despite a growing body of literature on 
fatigue after TBI, there is a lack of large-scale studies on 
longitudinal fatigue changes across both acute clinical care 
pathways, and injury severity. Such studies are important to 
increase the knowledge concerning which factors contribute 
the most to the occurrence and persistence of fatigue, as well 
as aid the development of preventive efforts and targeted 
fatigue interventions.
Several scales have been developed for the assessment of 
different aspects of fatigue for different purposes [5, 24, 40]. 
These scales often contain numerous questions [18], which 
may present a burden to the patients when other symptoms 
and aspects after TBI also need to be assessed. The River-
mead Post-Concussion Symptoms Questionnaire (RPQ) is a 
self-rated questionnaire assessing the presence and severity 
of common post-concussion symptoms after TBI [17, 39]. 
Fatigue is the most frequently affirmed symptom reported in 
the questionnaire, which renders this item useful to evaluate 
progress or regression of symptom severity [39]. In factor 
analysis of the RPQ, fatigue loads either on somatic/physio-
logical symptoms [31] or on emotional/somatic or cognitive 
symptoms [3], and is strongly associated with limitations 
in daily functioning [35]. Taken together, the single fatigue 
item in the RPQ seems to provide a good estimate of the sub-
jective experience of general fatigue after TBI. Therefore, 
we used it in a large sample of patients from the Collabora-
tive European NeuroTrauma Effectiveness Research in Trau-
matic Brain Injury (CENTER-TBI) observational study [22].
The aims of this study are:
1. To assess frequency and severity of fatigue at baseline 
(i.e., at time of study inclusion), 3 and 6 months post-
TBI across age, gender, patients’ clinical pathways in the 
acute phase and severity of injury.
2. To investigate whether socio-demographic factors, 
injury severity characteristics, and pre- and postinjury 
comorbidities predict fatigue changes across the first 
6 months following TBI.
We hypothesize that fatigue presents a significant burden 
for the majority of patients after TBI regardless of injury 
severity and time since injury.
Methods
Study design
Patients were selected from the core study of the CENTER-
TBI project; a multicenter, prospective observational longi-
tudinal cohort study, conducted in Europe and Israel [22], 
which enrolled patients with all severities of TBI who pre-
sented to 65 participating centers between December 19, 
2014 and December 17, 2017. Inclusion criteria were a clini-
cal diagnosis of TBI, an indication for CT scanning, present-
ing to a medical center within 24 h of injury, and obtained 
informed consent adhering to local and national ethical and 
legal requirements. Patients were excluded if there was a 
severe pre-existing neurological disorder that could poten-
tially bias outcome assessments (in this study self-reported 
fatigue). Three strata were used to prospectively differenti-
ate patients by clinical care pathway: emergency room (ER; 
patients evaluated in the ER and discharged afterwards), 
admission (ADM; patients admitted to a hospital ward) and 
intensive care unit (ICU; patients who were primarily admit-
ted to the ICU). The main descriptive findings of CENTER-
TBI have been published elsewhere [34].
Study participants
In total, 4509 participants were enrolled in the CENTER-
TBI core study. In the current study, all patients from the 
ER, ADM and ICU strata who answered the RPQ-fatigue 
question at least once at either baseline (mean 2.5 days 
following admission to CENTER-TBI), 3 or 6 months 
after injury were selected. Thus, 3354 patients (78% of 
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all included in the core study) were included in this study 
and their baseline characteristics are described in Table 1. 
Among these, 2286 had answered the RPQ-fatigue ques-
tion at baseline, 2164 at 3 months after injury, and 2253 
at 6 months after injury and were thus further analyzed in 
this study.
Measurements
Both adults (age group ≥ 16 years) and children and/or 
their parents (age group < 16 years) were asked to rate 
the severity of fatigue compared to their preinjury status 
during the last 24 h. Rating on a 5-point Likert scale was 
used, from 0 = “not a problem” to 4 = “severe problem”. 
A study assessing validity showed that RPQ was unbiased 
for an age range of 6–96 years [19], and parents ratings of 
Table 1  Characteristics of the 
study population
SD standard deviation; IQR interquartile range; ASA-PS American Society of Anesthesiologists Physical 
Status Classification System score; GCS Glasgow Coma Scale; AIS abbreviated injury severity score; ISS 
injury severity score







Gender, male % 2189 (65.3%) 449 (55.6%) 877 (64.9%) 863 (72.2%)  < 0.001
Age, years  < 0.001
 Mean (SD) 47.8 (21.0) 47.9 (20.7) 50.6 (21.6) 44.6 (20.0)
 Median (IQR) 49 (29, 65) 48 (29, 64) 53 (32, 67) 45 (27, 60)
Age categories, %  < 0.001
 0–18 years 259 (7.7%) 42 (5.2%) 102 (7.5%) 115 (9.6%)
 19–40 years 1040 (31.0%) 280 (34.7%) 357 (26.4%) 403 (33.7%)
 41–65 years 1258 (37.5%) 295 (36.5%) 498 (36.9%) 465 (38.9%)
  > 65 years 797 (23.8%) 191 (23.6%) 394 (29.2%) 212 (17.7%)
Education, years 0.041
 Mean (SD) 13.2 (4.2) 13.1 (4.1) 13.4 (4.3) 13.0 (4.2)
 Median (IQR) 13 (11, 16) 13 (11, 16) 13 (11, 16) 13 (11, 16)
Employment, %  < 0.001
 Working ≥ 35 h/week 1319 (39.3%) 329 (40.7%) 467 (34.6%) 523 (43.8%)
 Working < 35 h/week 310 (9.2%) 89 (11.0%) 127 (9.4%) 94 (7.9%)
 Student 408 (12.2%) 86 (10.6%) 161 (11.9%) 161 (13.5%)
 Retired 793 (23.6%) 199 (24.6%) 375 (27.8%) 219 (18.3%)
 Not working 524 (15.6%) 105 (13.0%) 221 (16.4%) 198 (16.6%)
Preinjury ASA-PS  < 0.001
 Healthy 1991 (59.9%) 462 (57.4%) 758 (56.6%) 771 (65.4%)
 Mild disease 1038 (31.2%) 258 (32.0%) 457 (34.1%) 323 (27.4%)
 Severe disease 293 (8.8%) 85 (10.6%) 124 (9.3%) 84 (7.1%)
Preinjury Psychiatry 415 (12.9%) 116 (15.1%) 154 (11.8%) 145 (12.5%) 0.088
Previous TBI (n = 3206)
329 (10.3%)
113 (14.5%) 135 (10.3%) 81 (7.2%)  < 0.001
Cause of injury  < 0.001
 Traffic accident 1247 (39.1%) 257 (32.9%) 446 (34.6%) 544 (48.6%)
 Incidental fall 1531 (48.0%) 400 (51.3%) 664 (51.6%) 467 (41.7%)
 Others 410 (12.9%) 123 (15.8%) 178 (13.8%) 109 (9.7%)
GCS categories, %  < 0.001
 GCS 13–15 2616 (80.2%) 794 (99.6%) 1285 (97.1%) 537 (47.1%)
 GCS 9–12 221 (6.8%) 2 (0.3%) 32 (2.4%) 187 (16.4%)
 GCS 3–8 424 (13.0%) 1 (0.1%) 6 (0.5%) 417 (36.5%)
AIS head (≥ 3), % 2094 (63.0%) 64 (7.9%) 946 (70.5%) 1084 (92.2%)  < 0.001
ISS, median (IQR) 13 (8, 25) 4 (2, 8) 10 (9, 17) 26 (18, 41)  < 0.001
CT head—presence of 
intracranial injury
1359 (42.2%) 71 (9.3%) 469 (36.6%) 819 (70.8%)  < 0.001
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fatigue in children with TBI have been applied in research 
previously [10].
The data were either collected in face-to-face inter-
views, or per postal or electronic questionnaires at 
baseline, (mean 2.5  days following study admission, 
SD ± 12.0), at 3 and at 6 months follow-ups. The cut-off 
value ≥ 2, corresponding to symptoms rated as mild, mod-
erate and severe, was used as one of the options of evalua-
tion of symptom severity [38]. However, in clinical prac-
tice, a sub-group of patients with moderate and/or severe 
fatigue symptoms may be challenging to treat because of 
its impact on general functioning and daily activities; thus, 
a cut-off value ≥ 3, corresponding to symptoms rated as 
moderate and severe was also applied.
Socio-demographic and injury-related characteristics 
that were collected at the time of study admission and 
used as independent variables included gender (female/
male), age (continuous, and categorical: 0–18, 19–40, 
41–64, > 65 years, and dichotomized at median value) and 
education (continuous, i.e. in years, and dichotomized at 
median value).
Preinjury somatic comorbidities were measured by the 
pre-injury American Society of Anesthesiologists Physical 
Status Classification System score (ASA-PS) [23].
Preinjury psychiatric conditions comprised anxiety, 
depression, sleep disorders, schizophrenia, drug abuse or 
other psychiatric problems as reported by patients retrospec-
tively at follow-up.
Injury-related variables were: injury mechanism (road 
traffic accident, falls, others); injury severity measured by 
patient strata, Glasgow Coma Scale (GCS) score/category 
within the first 24 h after injury [36], presence of intracra-
nial injuries on first CT head, Abbreviated Injury Scale head 
(AIS head, score ≥ 3 considered as severe intracranial injury) 
[15], and Injury Severity Score (ISS), where a score > 15 
was considered as major overall trauma [2].
Two additional items from RPQ were used to assess 
sleep disturbances and feeling depressed at baseline, and 
were applied as determinants of postinjury comorbidities of 
potential relevance for feeling fatigued. A cut-off score of ≥ 2 
(mild, moderate and severe problems) was used.
Statistical analysis
The CENTER-TBI dataset version 2.0 (dataset from May 
2019) was analyzed in this manuscript. The frequency of 
patients experiencing fatigue was assessed per patient strata, 
age group, gender and GCS severity level.
For descriptive statistics means with standard deviations 
(SD), medians with interquartile range (IQR), or percent-
ages are presented. Differences in demographic and injury 
related data between patients’ strata ER, ADM and ICU 
were tested using a one-way ANOVA or Kruskal–Wallis 
test for continuous variables. A chi-square test for contin-
gency tables was performed to detect group differences in 
categorical variables.
To analyze changes in fatigue between the patients’ strata 
over the entire follow-up period and account for repeated 
measures by patient, mixed effect logistic regression was 
performed using fatigue (dichotomized at the value ≥ 2) as 
the outcome variable. Time and time-by-patient strata inter-
action were introduced as fixed effects in all models. Based 
on the mixed effects logistic regression, we estimated risk 
differences with 95% confidence intervals (CI) from base-
line to 6 months using the delta method. For comparison of 
the effects of different cut-offs, the analysis was replicated 
using fatigue dichotomized at the value ≥ 3 as the outcome 
variable.
Further, mixed effect logistic regression analyses were 
performed to investigate whether changes of fatigue (dichot-
omized at the value ≥ 2/ ≥ 3) during the follow-up period 
(baseline, 3, and 6 months) could be predicted by age, gen-
der, patient strata, education, preinjury ASA-PS and psy-
chiatric comorbidities, GCS score, intracranial injury on 
CT, AIS head, ISS, and RPQ items `feeling depressed`, and 
`sleep disturbance` (dichotomized at the value of ≥ 2). Time 
and all predictor variables were treated as fixed effects in 
the models. Interaction effects between time and fixed fac-
tors were verified by introducing product terms. All mod-
els included a random intercept. Statistically significant 
fixed main effects or interaction effects on fatigue ≥ 2 were 
graphed across each of the three time points. In these figures, 
if the predictor was continuous a median-split procedure was 
used to generate separate lines as function of the predictor.
Missing predictor data were handled by multiple impu-
tations with ten imputations applying the Markov Chain 
Monte Carlo method [32]. Sensitivity analyses were per-
formed to handle missing values in predictor variables. The 
multiple imputed model was compared with the complete 
case analyses, and presented in results.
All statistical analyses were performed using IBM SPSS 
Statistics for Windows version 25 (Armonk, NY: IBM 
Corp.) and Stata 15 (Stata Corp LLC, College Station, TX).
Results
Table 1 shows demographic and injury characteristics by 
patient strata; 808 patients were included in the ER stra-
tum, 1351 in ADM, and 1195 in ICU. Median age of the 
total sample was 49 (IQR 29, 65) years and 65% of the 
participants were male. Median years of education was 13 
(IQR 11, 16) years. Socio-demographics and injury sever-
ity characteristics differed significantly between patient 
strata (Table 1). Severe TBI (GCS 3–8), severe intracranial 
injury (AIS head ≥ 3) and severe overall trauma (ISS > 15) 
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were observed in 37, 92 and 95% of patients in ICU stra-
tum, respectively.
Furthermore, 2286 patients reported on the fatigue item 
at baseline and were thus evaluated in this study. Of these, 
46.9% reported having fatigue (cut-off score ≥ 2). The fre-
quency was halved when using moderate/severe fatigue 
cut-off score (≥ 3) (22.8%). The median fatigue score 
was highest in the patients admitted to ICU (2, IQR 0–3, 
p = 0.001) where 57.6% reported moderate/severe fatigue. 
In ADM and ER strata, 48.2 and 39.0% participants expe-
rienced moderate/severe fatigue, respectively (Table 2). 
eTable 1 in the Supplement presents fatigue scores by 
age groups and patients’ strata. In the ER stratum, the 
highest prevalence of moderate/severe fatigue was in the 
age group 19–40 (22.4%); in the ADM stratum in the age 
group 0–18 (34.9%). The most frequently reported mod-
erate/severe fatigue was in the ICU stratum in age group 
0–18 (48.8%), and age groups 19–40 and 41–65 years 
(32.4 and 31.4%, respectively).
The frequency of fatigue by 10-year age groups and 
gender is presented in Fig. 1. Overall, 52.5% of females 
and 43.6% of males reported fatigue; the frequency was 
highest in females across all age groups. The highest 
frequency of moderate/severe fatigue (≥ 3) was found 
for females aged 50–60 years (38.3%) and males aged 
0–10  years (46.4%), and the lowest in females aged 
60–70 years (20.3%) and males > 70 years (8.5%).
Changes of fatigue across 6 months follow‑up
The estimated proportions of fatigue score ≥ 2 and ≥ 3 by 
patients strata are reported in Fig. 2a, b.
Overall, there were no statistically significant differ-
ences in fatigue proportions between patient strata`s across 
the first 6 months post injury. However, significant within 
group differences due to a decrease in fatigue scores ≥ 2 were 
found in the ER (mean change − 7.2, 95%CI − 12.0 to − 2.4, 
p = 0.003) and ADM (mean change: − 7.7, 95% CI − 11.5 
to − 3.8, p < 0.001) strata from baseline to 6 months, but not 
for the ICU group (mean change − 2.0, 95%CI − 7.2 to 3.2, 
p = 0.454). When applying cut-off ≥ 3, representing mod-
erate and severe fatigue, no such reduction was observed, 
indicating more persistence of severe symptoms compared 
to mild.
Similar results were found in the modeling of changes of 
fatigue scores ≥ 2 and the score ≥ 3 by GCS severity catego-
ries supporting the notion that the clinical pathways in the 
acute TBI phase are indicators of injury severity (eFigures 1 
a and 1b and eTable 2 in the Supplement).
Predictors of fatigue changes
Two models used in the predictive analyses examined 
whether changes of fatigue scores ≥ 2 (model 1) and ≥ 3 
(model 2) over time could be predicted by demographic 
variables, injury severity indicators and comorbidities. All 
statistically significant and non-significant fixed effects from 
the full model and their coefficients, p-values, and 95% con-
fidence intervals are presented in Table 3.
In model 1, the ICU patient stratum, age, gender, educa-
tion, preinjury ASA-PS, AIS head, ISS, feeling depressed, 
and sleep disturbance yielded significant effects on fatigue 
Table 2  Fatigue severity scores 
at baseline by patient strata
ER emergency room; ADM admission; ICU intensive care unit; IQR interquartile range









Median (IQR) 1 (0, 2) 0 (0, 2) 1 (0, 2) 2 (0, 3)  < 0.001
Severity of fatigue  < 0.001
 None (0–1) 1215 (53.1%) 454 (60.9%) 592 (51.8%) 169 (42.4%)
 Mild problem (2) 549 (24.0%) 160 (21.5%) 285 (25.0%) 104 (21.6%)
 Moderate or severe prob-
lem (3–4)
522 (22.8%) 131 (17.6%) 265 (23.2%) 126 (31.6%)
Fatigue scores ≥ 2 1071 (46.9%) 291 (39.1%) 550 (48.2%) 230 (57.6%)  < 0.001
Fig. 1  Frequency of patients with Fatigue (≥ 2) by 10-year age groups 
and gender at study admission
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probability changes. Patients admitted to ICU had a higher 
probability of experienced fatigue than those admitted to ER 
and ADM strata. In addition, patients with lower age, higher 
education, more severe injuries as assessed by AIS head and 
ISS, with pre-injury somatic and psychiatric diseases and 
postinjury comorbidity (sleep disturbance and feelings of 
depression) and females had a higher probability of fatigue.
The significant interaction effect between time and age 
suggested that the patient group < 49 years tended to report 
higher fatigue scores initially and then decreased over 
time, e.g. reported less fatigue, whereas patients ≥ 49 years 
reported less fatigue symptoms initially and then fatigue 
slightly increased over time (Fig. 3).
The significant interaction effect between time and 
education suggested that patients with higher education 
(≥ 13 years) tended to report higher fatigue scores initially 
and then decreased over time, whereas those with lower edu-
cation reported less fatigue initially, and then slightly higher 
fatigue scores during the first 3 months (Fig. 4).
The significant interaction effect between time and pre-
injury psychiatric conditions suggested that patients with 
known psychiatric problems tended to report higher fatigue 
scores at baseline and then slightly increased scores over 
time, whereas those without psychiatric conditions reported 
decreased scores over time (Fig. 5).
The significant interaction effects between time and feel-
ing depressed and sleep disturbance suggested that patients 
who reported feeling depressed and sleep disturbance (cut-
off ≥ 2) tended to report higher fatigue scores initially, then 
less over the next 3 months and stable levels during the last 
3 months. (eFigures 2 and 3 in the Supplement).
In model 2, the same predictors were statistically sig-
nificant as in model 1 (except the ICU stratum) indicating 
that the assessed fatigue predictors are of major importance 
across all fatigue severity levels.
Discussion
This large-scale, observational longitudinal study assessed 
the frequency of fatigue following TBI, fatigue changes 
across clinical care pathways, severity of injury, and pre-
dictors of fatigue severity levels.
Fatigue is a widespread symptom in the acute and post-
acute TBI phase [39]. As expected, we found a high fre-
quency of fatigue throughout the whole sample included in 
this study: around 47% of patients reported subjective fatigue 
of any severity (cut-off ≥ 2) at baseline, 48% at 3 months 
and 46% at 6 months. These frequencies were halved when 
cut-off ≥ 3 (moderate and severe fatigue) was used. Females 
and patients of younger age (≤ 40 years) reported higher 
frequency of fatigue at baseline. The frequency of fatigue 
was highest in the patients admitted to the ICU, those with 
moderate and severe TBI, and more severe intracranial inju-
ries and overall trauma. Our results suggest that more severe 
TBI may increase the risk of fatigue probably due to the 
neuro-morphological brain damage as discussed later. How-
ever, this is in contrast with previous research that reports no 
increased risk of fatigue in those with more severe TBI [24].
In line with our expectations, level of fatigue stayed quite 
stable over the first 6 months post-TBI, particularly, the 
moderate and severe levels (fatigue cut-off ≥ 3). As fatigue 
has an unfavorable effect on participation in activities of 
daily life [4], the results indicate that we should identify 
those with higher levels of fatigue early after the injury, and 
provide further assessments, timely advices, and targeted 
rehabilitation programs.
Demographic factors such as age, gender, and educa-
tion were associated with fatigue levels in this study. As 
mentioned previously, findings regarding the association 
between fatigue following TBI and demographic factors 
Fig. 2  a Estimated proportions of patients with Fatigue ≥ 2 by patient 
strata. b Estimated proportions of patients with Fatigue ≥ 3 by patient 
strata
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are inconsistent in the literature. For example, Cantor et al. 
[7] did not find any association between age, gender, edu-
cation and fatigue. In our study, lower age was associ-
ated with higher levels of fatigue, probably reflecting the 
TBI severity in this population (33% of patients in age 
group ≤ 40 years had severe TBI, in contrast to 20% of 
patients in age group > 40 years).
We found that females reported greater levels of fatigue 
compared to males, in line with previous studies [12]. In 
studies on self-reported symptoms following TBI, women 
are more likely to report problems across different symptom 
domains [14]. Furthermore, post-concussion symptoms and 
especially fatigue is prevalent in the general population as 
well [37]. However, previous research has suggested that 
gender differences in socialization and gender-role expecta-
tions may change over time and moderate the relationship 
between gender and outcome measures after TBI [9, 25].
We also found an association between higher levels of 
education and greater severity of fatigue, which is in line 
with study by Ziino & Ponsford [41]. This may relate to a 
Table 3  Predictors of fatigue (imputed predictors)
ER emergency room; ADM admission; ICU intensive care unit; ASA-PS American Society of Anesthesiologists Physical Status Classification 
System score; GCS Glasgow Coma Scale; AIS abbreviated injury severity score; ISS injury severity score.
Model 1: Fatigue cut-off ≥ 2, Model 2: Fatigue cut-off ≥ 3. * = p < 0.05; ** = p < 0.01; *** = p < 0.001
Model 1 Model 2
Coef 95% CI p value Coef 95% CI p value
Intercept − 0.83*** − 1.43 to − 0.22 0.007 − 2.21 − 2.88 to − 1.55  < 0.001
Time − 0.18 − 0.31 to − 0.04 0.012 − 0.04 − 0.20 to 0.11 0.596
Patient strata
 ER Ref
 Adm 0.30 − 0.02 to 0.62 0.070 0.16 − 0.23 to 0.54 0.425
 ICU 0.61** 0.13 to 1.09 0.013 0.45 − 0.10 to 0.99 0.109
Age, y − 0.02*** − 0.03 to − 0.02  < 0.001 − 0.02*** − 0.03 to − 0.01  < 0.001
Gender (f = 0, m = 1) − 0.62*** − 0.86 to − 0.38  < 0.001 − 0.60*** − 0.87 to − 0.33  < 0.001
Education, y 0.05** 0.02 to 0.07 0.001 0.04* 0.01 to 0.07 0.007
Preinjury ASA-PS
 Healthly patients Ref
 Mild disease 0.28* 0.004 to 0.56 0.047 0.19 − 0.13 to 0.51 0.244
 Severe disease 0.47* 0.03 to 0.91 0.034 0.55* 0.06 to 1.04 0.028
Preinjury psychiatry 0.12 − 0.23 to 0.47 0.491 0.20 − 0.19 to 0.58 0.321
GCS (3–15) 0.08 − 0.19 to 0.35 0.565 0.05 − 0.23 to 0.33 0.727
CT head intracranial injury 0.08 − 0.20 to 0.36 0.577 0.01 − 0.30 to 0.32 0.961
AIS head (≥ 3) 0.35* 0.03 to 0.67 0.034 0.54** 0.17 to 0.91 0.004
ISS 0.02* 0.00004 to 0.03 0.049 0.02* 0.00002 to 0.03 0.050
Feeling depressed at baseline 1.26*** 0.94 to 1.57  < 0.001 1.55*** 1.08 to 2.02  < 0.001
Sleep disturbance at baseline 1.18*** 0.91 to 1.45  < 0.001 1.82*** 1.47 to 2.18  < 0.001
Time × Significant predictors
 Time × ICU 0.04 − 0.08 to 0.15 0.537 0.04 − 0.09 to 0.17 0.568
 Time × Age 0.005*** 0.003 to 0.01  < 0.001 0.004*** 0.002 to 0.01  < 0.001
 Time × Gender − 0.01 − 0.06 to 0.05 0.811 − 0.01 − 0.07 to 0.05 0.666
 Time × Education − 0.01* − 0.01 to -0.002 0.014 − 0.01* − 0.02 to − 0.002 0.009
 Time × Preinjury ASA-PS
 Time × Mild disease − 0.01 − 0.07 to 0.05 0.747 0.01 − 0.06 to 0.08 0.743
 Time × Severe disease 0.02 − 0.08 to 0.13 0.654 − 0.004 − 0.11 to 0.11 0.942
 Time × Preinjury psychiatry 0.12** 0.04 to 0.20 0.004 0.09* 0.0001 to 0.18 0.050
 Time × AIS head 0.01 − 0.07 to 0.09 0.788 − 0.04 − 0.13 to 0.05 0.336
 Time × ISS 0.0004 − 0.003 to 0.004 0.821 − 0.001 − 0.004 to 0.003 0.601
 Time × Feeling Depressed − 0.16*** − 0.23 to − 0.09  < 0.001 − 0.26*** − 0.37 to − 0.14  < 0.001
 Time × Sleep disturbance − 0.15*** − 0.21 to − 0.08  < 0.001 − 0.22*** − 0.31 to − 0.14  < 0.001
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trend in the general population where people with higher 
education report more symptoms, possibly related to them 
having a better understanding of health problems and health 
care services utilization [11]. Another possible explanation 
may be related to the concept of cognitive reserve, i.e. the 
fact that education seems to contribute to higher levels of 
cognitive functioning throughout the life-span, which again 
may result in individuals with higher education coping better 
with TBI-related cognitive impairments. However, as people 
with higher levels of education often work in cognitively 
demanding professions, the subjective experience of fatigue 
may hamper the use of cognitive reserves, causing fatigue to 
feel relatively more detrimental to these persons. Given the 
mixed results in the current literature regarding the associa-
tion between education and fatigue levels, future studies on 
the relationship between education, cognitive reserve and 
fatigue after TBI are needed.
Furthermore, the present results support a relationship 
between fatigue and more severe TBI and overall trauma. 
This was indicated by several significant predictors includ-
ing the ICU stratum, AIS head ≥ 3 and higher ISS score, 
all affecting the fatigue levels in this study. Some studies 
have indicated that post-TBI fatigue was positively asso-
ciated with greater severity of injury [33] whereas others 
have failed to demonstrate an association between fatigue 
and injury severity [24, 28, 41]. Methodological differences 
between studies may explain these discrepancies. Still, it is 
worth mentioning that previous studies have suggested that 
intracranial injuries such as traumatic axonal injury (TAI), 
global and regional thalamic morphometric changes and 
functional connectivity in the thalamus and middle frontal 
cortex may contribute to fatigue following TBI [8, 13, 26]. 
However, there are only few studies on this topic, and further 
research on the association between neuro-morphological 
brain injury and fatigue following TBI is needed.
Presence of preinjury (i.e. somatic disease and psychi-
atric conditions) and postinjury comorbidities (i.e., feel-
ing depressed and sleep disturbance) also predicted fatigue 
levels. Participants with preinjury psychiatric conditions, 
those with depressive feelings and sleep problems were at 
risk of unfavorable fatigue outcomes in this study. Previous 
TBI studies with mixed severity samples [6, 12] have dem-
onstrated the association between these comorbidities and 
fatigue. This is of importance to the field of rehabilitation 
given the impact these symptoms may have on daily activity 
levels and health-related quality of life. Treating the symp-
toms that co-occur with and interact with fatigue such as 
premorbid psychiatric problems, ongoing depression, sleep 
problems, and pain and finding a balance between rest and 
activities (i.e., pacing) is currently the best recommendations 
for fatigue treatment [30].
Overall, the same factors predicted fatigue regardless of 
the cut-off (≥ 2 or ≥ 3) applied, indicating the reliability of 
Fig. 3  Main effect and time interaction of age on fatigue changes
Fig. 4  Main effect and time interaction of education on fatigue 
changes
Fig. 5  Time interaction of preinjury psychiatric comorbidity on 
fatigue changes
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predictors used in the study. Time since injury interacts with 
a range of predictors, but does not predict changes on its 
own, whereas injury severity appears to be a robust pre-
dictor. The study findings may help health professionals to 
plan individualized therapy and rehabilitation programs in 
the early stages of recovery for patients with specific demo-
graphic and injury characteristics and comorbidities.
Limitations
These findings may not be generalizable to all European 
individuals who have sustained a TBI since participants 
were mainly recruited from trauma referral centers. As such, 
the findings are not necessarily generalizable to individuals 
sustaining a minimal TBI or a mild TBI without indication 
for a CT head. One of the major limitations of this study is 
the use of a single item operationalization of fatigue; never-
theless, it was the only opportunity to measure fatigue and 
its changes when using the CENTER-TBI data. The word-
ing of the item asks whether fatigue has been a problem for 
the past 24 h compared to before the injury. The experience 
of symptoms, however, can vary, and may be related to the 
level of activity at the time of assessment. This raises the 
possibility that the reported ratings of fatigue symptoms are 
not reflective of the overall experience (i.e., both over- and 
underreporting possible). Using fatigue assessment instru-
ments with established validity in specific patient groups is 
recommended [40]; yet, such instruments were not available 
in this study. Further, usage of specific fatigue tools may 
not be as achievable in a hectic clinical setting as the broad 
current use of the RPQ, thus our results may be more easily 
transferrable to common clinical practice.
Fatigue after TBI has increasingly been conceptualized 
as a complex condition, with a number of factors that may 
contribute to its development and persistence [30]. Variables 
included in our predictive models were selected based on 
clinical importance and previous studies on TBI. Addition-
ally, other variables such as preinjury fatigue symptoms, 
neurocognitive function, structural brain abnormalities, 
potential blood biomarkers, and hormonal imbalance not 
included in this study should be assessed in future studies. 
Taken together, translational research is needed to advance a 
clinical decision-making process and targeted medical treat-
ment of fatigue in the future.
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